On February 1, 2005. Washington D.C. Councilman David introduced the
Prescription Drug Compulsory Manufacture License Act of 2005. The bill
would allow the D.C. government to issue compulsory licenses to FDA-approved
firms for the production of generics. The expected savings would be
re-invested into community healthcare. In March, the legislation passed the
Committee on Health, and the full City Council will consider the bill on
April 5, 2005.
|Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> Compulsory Licensing|